Philips Appoints Technology Chief and First Chief AI Officer
Article excerpt
“Philips’ purpose - to improve people’s health and well-being through meaningful innovation - has never felt more relevant,” writes Laura on LinkedIn. “I look forward to working with new colleagues, customers and partners to connect science, technology, data and digital capabilities in ways that create real value for patients, healthcare professionals and consumers,” she continues. Philipp Harbach will take over as Chief Science and Technology Officer at Merck KGaA on an interim basis following Laura’s departure. Merck KGaA is a global science and technology company spanning healthcare, life sciences and electronics. Its healthcare business develops innovative medicines and technologies across oncology, immunology, neurology and fertility, while its Life Science division supplies tools and solutions supporting pharmaceutical research, bioprocessing and healthcare innovation worldwide. WellSpan Health CEO: Roxanna Gapstur | HQ: York, Pennsylvania In June 2026, WellSpan Health partnered with Philips on a seven-year strategic alliance spanning advanced imaging, diagnostics, AI and research. The collaboration will see the organisations co-develop and validate new technologies across WellSpan’s 12 hospitals and wider network. The partnership aims to improve clinical workflows, efficiency and patient care. Edwards Lifesciences CEO: Bernard Zovighian | HQ: Irvine, California...
Keep reading with a free account
The rest of this article, and every signal for Philips, is in your free account.
Extracted from this sentence
Philips and Edwards Lifesciences collaborated to develop DeviceGuide, an AI-powered solution providing real-time guidance during minimally invasive mitral valve repair.
